FindTrial
Sign In

Beijing Osteoporosis with Neurological disease in Epigenetic changes study

Beijing Osteoporosis with Neurological disease in Epigenetic changes: an ambispective, multicentre, open cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17014059
Enrollment
Unknown
Registered
2017-12-20
Start date
2017-12-20
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis with Neurological disease

Interventions

Cohort 1:Nil
Cohort 2:Nil

Sponsors

National Natural Science Foundation of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1) Aged >=45 years; 2) Hospital Orthopaedic Outpatient clinic, hospitalized patient; 3) DEXA.

Exclusion criteria

Exclusion criteria: 1) patients with a side of the disease, multiple myeloma, bone metastases and other serious diseases affecting bone or calcium metabolism; 2) complicated with severe liver and kidney insufficiency.

Design outcomes

Primary

MeasureTime frame
DEXA;MMSE;—

Countries

China

Contacts

Public ContactDongwei Fan; Zhongqiang Chen

Peking University Third Hospital, Orthopeadic department

chenzq@bjmu.edu.cn+86 10 82265557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026